Annual sales went from KRW 722.2 billion in 2022 to KRW 726.4 billion in 2023 (up 0.6% year on year), the peak of the period. Sales then fell to KRW 704.5 billion in 2024 (down 3.0%) and KRW 567.2 billion in 2025 (down 19.5%), a two-year decline from 2024 through 2025.
Within 2022–2025, 2023 was the largest year and 2025 the smallest.
Operating results moved from an operating loss of KRW 13.5 billion in 2022 to operating profit of KRW 8.73 billion in 2023, a turn to profit, then to an operating loss of KRW 18.9 billion in 2024, a turn to loss, and back to operating profit of KRW 20.7 billion in 2025, a turn to profit.
The operating margin improved from -1.9% in 2022 to 1.2% in 2023, -2.7% in 2024 and 3.6% in 2025. Net profit attributable to controlling shareholders was KRW 5 billion in 2023 and KRW 23.4 billion in 2025, while 2022 and 2024 posted losses of KRW 13.1 billion and KRW 30 billion.
Net profit including non-controlling interests is a different figure, at KRW 32 billion for 2025. Industry reports cited the loss of some in-licensed products as a factor behind the 2025 sales decline.
The debt-to-equity ratio fell from 193.6% in 2022 and 210.3% in 2023 to 139.7% in 2024 and 103.4% in 2025, with total equity at KRW 251 billion at the end of 2025, of which KRW 211.1 billion was attributable to controlling shareholders, and total liabilities at KRW 259.5 billion.
Operating cash flow was positive at KRW 3.21 billion in 2024 but negative at -KRW 5.69 billion in 2025. By quarter, operating profit of KRW 9.82 billion in the third quarter of 2025 was followed by KRW 534 million in the fourth quarter, down 94.6% from the prior quarter.
Operating profit was KRW 418 million in the first quarter of 2026, followed by an operating loss of KRW 7.04 billion in the second quarter, a turn to loss, and an operating loss of KRW 6.25 billion in the third quarter, making two consecutive loss-making quarters from the second through the third quarter of 2026.
Third-quarter 2026 sales were KRW 136.7 billion, up 1.4% year on year, but gross profit fell 4.4% to KRW 52.1 billion and SG&A rose 30.5% to KRW 58.4 billion, according to reporting on that quarter.
The same reporting put recurring R&D expenses at KRW 16.6 billion, up 73%, and the company attributed the profitability decline mainly to higher R&D spending.
Net loss attributable to controlling shareholders was KRW 310 million in the first quarter of 2026, KRW 8.02 billion in the second and KRW 5.64 billion in the third, three straight loss quarters with a combined KRW 6.6 billion loss over the last four quarters.